eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2022
vol. 39
 
Share:
Share:
more
 
 
abstract:
Review paper

The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus

Aleksandra Frątczak 
1
,
Karina Polak
1
,
Michał Szczepanek
1
,
Anna Lis-Święty
1

1.
Department of Dermatology, Medical University of Silesia, Katowice, Poland
Adv Dermatol Allergol 2022; XXXIX (4): 645-650
Online publish date: 2022/09/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Inflammation and atherogenic dyslipidaemia are often observed in skin diseases and represent an increased risk of cardiovascular disorders. Proprotein convertase subtilisin/kexin type 9 plays an important role in the regulation of serum low-density lipoprotein cholesterol levels. Its biological role, however, seems to go much beyond the regulation of cholesterol metabolism. The article presents potential pathophysiological links between inflammatory process and lipid disorders based on the example of psoriasis and systemic lupus erythematosus.
keywords:

PCSK9, evolocumab, alirocumab, psoriasis, systemic lupus erythematosus

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.